期刊文献+

肝素末端结合修饰猪肝去细胞化支架材料的抗凝性能研究 被引量:1

Anticoagulant property of the decellularized porcine liver biological material scaffolds heparinized by end-point attachment
下载PDF
导出
摘要 目的通过对猪肝去细胞化材料进行肝素末端结合修饰,改善其作为肝脏组织工程支架材料的抗凝血性能.方法实验用巴马香猪3只,猪龄3~4个月,体质量15kg。取猪肝脏,采用1%十二烷基磺酸钠+1%曲拉通X-100门静脉灌注获得去细胞化支架材料。对支架材料进行末端连接(EPA)肝素化修饰,之后,检测了它们的肝素化效果及抗凝血性能。结果去细胞化材料经肝素化修饰后结合上了肝素。材料中肝素总含量为(16.00±0.01)μg/mg,并逐渐释放。材料抗凝血性能指标与未经处理的去细胞化材料相比有明显改善,凝血酶时间(TT)、凝血酶原时间(PT)、活化部分凝血活酶时间(AFIT)均超过检测仪器最大值;复钙时间延长达(350.3±29.1)s,具有良好的抗凝性能:溶血实验表明.修饰材料符合生物材料的溶血性要求,血液相容性好。结论在体外研究中,EPA肝素化修饰的去细胞化材料获得良好的抗凝血性能. Objective To enhance the anticoagulant properties of the heparin modified decellularized porcine liver biological materials as the scaffold for tissue engineering research. Methods Three Bama miniature pigs were enrolled, which were aged 3 - 4 months with body weight of 15 kg. The pig livers were taken, and decellularized scaffolds were prepared by portal perfusion with 1% sodium dodecyl sulfate + 1% Triton X-100. The decellularized porcine liver scaffolds were immobilized with heparin by end-point attachment(EPA), and the effect of heparinization and anticoagulant property were tested. Results The scaffolds were immobilized with heparin and the content of heparin in the scaffolds was (16.00 ± 0.01) μg/mg, which was gradually released. The heparinized scaffolds demonstrated better anticoagulant property than the untreated scaffolds. The thrombin time(TT), prothrombin time (PT) and activated partial thromboplastin time (APTT) of the scaffolds immobilized with heparin by EPA exceeded the maximum measurement capability of the instrument. The re-calcification time of the scaffolds was extended to (350.3 ± 29.1) seconds. The hemolytic test showed good blood compatibility, and the heparinized materials met with the requirements for biomaterials. Conclusion It is demonstrated that the decellularized biological materials for tissue engineering acquired stronger anticoagulant ability in vitro via EPA heparinization technique.
出处 《生物医学工程与临床》 CAS 2014年第3期209-213,共5页 Biomedical Engineering and Clinical Medicine
基金 四川省科技支撑计划项目(2012SZ0016) 中国国家自然科学基金资助项目(81200315) 教育部高等学校博士学科点专项科研基金资助项目(20120181110090) 中国博士后科学基金资助项目(2011M501413 2013T60855)
关键词 肝脏 去细胞化 末端连接 肝素化 抗凝 liver decellarization end-point attachment(EPA) heparinization anticoagulant
  • 相关文献

参考文献16

  • 1Haecker SA, Nelsen B, Taylor DA. Commercialization of the D- ECELI/RECELL technology platform[C]. World Stein Cell Rep- ort, 2008.
  • 2Teebken OE, Haverich A. Tissue engineering of small diameter vascular grafts[J]. Eur J Vascul Endovascul Surg, 2002, 23(6): 475-485.
  • 3Montanaro L, Arciola C, Cenni E, et al. Cytotoxicity, blood com- patibility and antimicrobial activity of two cyanoacrylate glues f- or surgical use[J]. Biomaterials, 2000, 22(1): 59-66.
  • 4Wang XH, Zhang F, Li CR, et al. Improvement of blood compati- bility of artificial heart valves via titanium oxide film coated on low temperature isotropic carbon[J]. Surface and Coatings Tech- nology, 2000, 128-129: 36-42.
  • 5Tsai CC, Chang Y, Sung HW, et al. Effects of heparin immobiliz- ation on the surface characteristics of a biological tissue fixed w- ith a naturally occurring crosslinking agent(genipin): An in vitro study[J]. Biomaterials, 2001, 22(6): 523-533.
  • 6刘秀英,张超灿,徐卫林.甲苯胺蓝分光光度法测定肝素钠的研究[J].化学试剂,2009,31(4):271-274. 被引量:16
  • 7Lu Q, Zhang S, Hu K, et al. Cytocompatibility and blood compat- ibility of multifunctional fibroin/collagen/heparin scaffolds[J]. B- iomaterials, 2007, 28(14): 2306-2313.
  • 8Lv Q, Cao C, Zhu H. A novel solvent system for blending of poly- urethane and heparin [J]. Biomaterials, 2003, 24 (22): 3915- 3919.
  • 9牟善松,屠美,汤顺清,周长忍.羟基磷灰石对硅橡胶复合材料抗凝血性能的影响(英文)[J].材料科学与工程学报,2003,21(2):162-164. 被引量:7
  • 10李沁华,邹翰.类肝素聚乙烯醇复合材料抗凝血性能的研究[J].中国生物医学工程学报,1999,18(1):15-21. 被引量:11

二级参考文献61

  • 1朱瑞宜.聚乙烯醇接枝共聚膜的研究[J].化学世界,1978,10:451-455.
  • 2高出茂树.PVA-HEMA-AN接枝膜的机械性能[J].日本高分子论文集,1980,37(7):449-457.
  • 3周自永.新编常用药手册[M].北京:金盾出版社,1987.290.
  • 4DAMUS P S, HICKS M, ROSENBERG R B. Anticoagulant action of heparin[J]. Nature, 1973,246(5432):355-357.
  • 5CASU B. Structure and biological activity of heparin [ J ]. Adv. Carbohydr. Chem. Biochem. , 1985,43:51-134.
  • 6《中国药物大全》编委会.中国药物大全[M].北京:人民卫生出版社,1991:155.
  • 7LUONG-VAN E, GRt21NDAHL L, CHUA K N, et al. Controlled release of heparin from poly(e-caprolactone) electrospun fibers[J]. Biomaterials ,2006,27(9) :2 042-2 050.
  • 8MOON H T, LEE Y, HAN J K,et al. A novel formulation for controlled release of heparin-DOCA conjugate dispersed as nanoparticles in polyurethane film [ J ]. Biomaterials, 2001,22 (3) :281-289.
  • 9SMITH P K, MALLIA A K, HERMANSON G T. Colorimetric method for the assay of heparin content in immobilized heparin preparations [ J ]. Anal. Biochem. , 1980, 109 ( 2 ) : 466- 473.
  • 10LUO Hong-qun, LIU Shao-pu, LIU Zhong-fang, et al. Resonance rayleigh scattering spectra for studying the interaction of heparin with some basic phenothiazine dyes and their analytical applications [ J ]. Anal. Chim. Acta, 2001,449 ( 1 ) : 261-270.

共引文献72

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部